[Selection of anti-arrhythmia agents].

Nihon Rinsho

Published: March 1983

Download full-text PDF

Source

Publication Analysis

Top Keywords

[selection anti-arrhythmia
4
anti-arrhythmia agents]
4
[selection
1
agents]
1

Similar Publications

Landiolol, an ultra-short-acting β1-selective blocker, is more effective in controlling heart rate compared with digoxin in patients with atrial tachyarrhythmias and left ventricular dysfunction. However, the effect of atrial tachyarrhythmia type on the effectiveness of landiolol remains unknown. Hence, this study aimed to evaluate the effectiveness of landiolol in patients with atrial fibrillation (AF) and atrial tachycardia (AT), not limited to those with heart failure with a reduced ejection fraction.

View Article and Find Full Text PDF

Atrial Fibrillation in Heart Failure: Novel Insights, Challenges, and Treatment Opportunities.

Curr Heart Fail Rep

November 2024

Tulane Research Innovation for Arrhythmia Discovery (TRIAD), New Orleans, LA, USA.

Purpose Of Review: Atrial fibrillation and heart failure frequently co-exist. This review discusses the comorbidity of atrial fibrillation and heart failure, the bi-directional link between them, and the recent advances in the management of these co-existing diseases.

Recent Findings: Catheter ablation received a class 1 A recommendation for patients with AF and HF, after overwhelming evidence in heart failure with reduced ejection fraction and end-stage heart failure, while clinical trials are still lacking in patients with preserved ejection.

View Article and Find Full Text PDF

Introduction: Current guidelines recommend electrophysiological study (EPS) and ablation for primary treatment of supraventricular tachycardia (SVT), but there is little information to guide patient selection for the procedure. The purpose of this study was to identify preoperative features that would predict whether patients with signs or symptoms of tachycardia were likely to have SVT induced and ablated at EPS.

Methods: We performed a retrospective chart review of 1089 patients referred for EPS and ablation of SVT at 2 high volume centers.

View Article and Find Full Text PDF

[Antiarrhythmic drugs will no longer be of importance in the treatment of atrial fibrillation in the future : Pros and cons].

Herzschrittmacherther Elektrophysiol

December 2024

Abteilung für Kardiologie, Angiologie und Pneumologie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.

An early rhythm stabilization is the primary focus of the current treatment of atrial fibrillation. Based on current studies catheter ablation of pulmonary vein isolation (PVI) is an established component in the treatment of atrial fibrillation. Therefore, in the management of affected patients this procedure should be offered at an early stage in addition to the holistic treatment approach with consistent treatment of cardiovascular risk factors and thromboembolism prophylaxis with anticoagulants.

View Article and Find Full Text PDF

Plasma Proteomic Insights for Identification of Novel Predictors and Potential Drug Targets in Atrial Fibrillation: A Prospective Cohort Study and Mendelian Randomization Analysis.

Circ Arrhythm Electrophysiol

October 2024

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Office of Beijing Cardiovascular Diseases Prevention, Beijing, China.

Article Synopsis
  • - The study aimed to develop reliable methods to predict and prevent atrial fibrillation (AF) by identifying specific plasma proteins associated with the condition, using data from the UK Biobank involving 38,784 participants.
  • - Researchers found 21 proteins linked to AF, with COL4A1 and RET showing significant causal relationships; RET is considered a potential drug target.
  • - The inclusion of COL4A1 greatly improved the predictive ability of existing AF models, demonstrated by various statistical performance metrics.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!